U.S. flag

An official website of the United States government

NM_001079802.2(FKTN):c.403_404insGCCTAAATCT (p.Phe135fs) AND Walker-Warburg congenital muscular dystrophy

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 11, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000686455.3

Allele description

NM_001079802.2(FKTN):c.403_404insGCCTAAATCT (p.Phe135fs)

Gene:
FKTN:fukutin [Gene - OMIM - HGNC]
Variant type:
Insertion
Cytogenetic location:
9q31.2
Genomic location:
Preferred name:
NM_001079802.2(FKTN):c.403_404insGCCTAAATCT (p.Phe135fs)
HGVS:
  • NC_000009.12:g.105604248_105604249insGCCTAAATCT
  • NG_008754.1:g.51119_51120insGCCTAAATCT
  • NM_001079802.2:c.403_404insGCCTAAATCTMANE SELECT
  • NM_001198963.2:c.403_404insGCCTAAATCT
  • NM_001351496.2:c.403_404insGCCTAAATCT
  • NM_001351497.2:c.334_335insGCCTAAATCT
  • NM_001351498.2:c.403_404insGCCTAAATCT
  • NM_001351499.2:c.7_8insGCCTAAATCT
  • NM_001351500.2:c.7_8insGCCTAAATCT
  • NM_001351501.2:c.7_8insGCCTAAATCT
  • NM_001351502.2:c.7_8insGCCTAAATCT
  • NM_006731.2:c.403_404insGCCTAAATCT
  • NP_001073270.1:p.Phe135fs
  • NP_001073270.1:p.Phe135fs
  • NP_001185892.1:p.Phe135fs
  • NP_001338425.1:p.Phe135fs
  • NP_001338426.1:p.Phe112fs
  • NP_001338427.1:p.Phe135fs
  • NP_001338428.1:p.Phe3fs
  • NP_001338429.1:p.Phe3fs
  • NP_001338430.1:p.Phe3fs
  • NP_001338431.1:p.Phe3fs
  • NP_006722.2:p.Phe135fs
  • LRG_434t1:c.403_404insGCCTAAATCT
  • LRG_434t2:c.403_404insGCCTAAATCT
  • LRG_434:g.51119_51120insGCCTAAATCT
  • LRG_434p1:p.Phe135fs
  • LRG_434p2:p.Phe135fs
  • NC_000009.11:g.108366528_108366529insTGCCTAAATC
  • NC_000009.11:g.108366529_108366530insGCCTAAATCT
  • NM_001079802.1:c.403_404insGCCTAAATCT
  • NR_147213.2:n.618_619insGCCTAAATCT
  • NR_147214.2:n.526_527insGCCTAAATCT
Protein change:
F112fs
Links:
dbSNP: rs1564290459
NCBI 1000 Genomes Browser:
rs1564290459
Molecular consequence:
  • NM_001079802.2:c.403_404insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001198963.2:c.403_404insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351496.2:c.403_404insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351497.2:c.334_335insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351498.2:c.403_404insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351499.2:c.7_8insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351500.2:c.7_8insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351501.2:c.7_8insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351502.2:c.7_8insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_006731.2:c.403_404insGCCTAAATCT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_147213.2:n.618_619insGCCTAAATCT - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_147214.2:n.526_527insGCCTAAATCT - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Walker-Warburg congenital muscular dystrophy
Synonyms:
Muscular dystrophy-dystroglycanopathy, type A; Walker-Warburg syndrome
Identifiers:
MONDO: MONDO:0000171; MedGen: C0265221; Orphanet: 899; OMIM: PS236670

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000813974Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Apr 11, 2018)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy.

Godfrey C, Escolar D, Brockington M, Clement EM, Mein R, Jimenez-Mallebrera C, Torelli S, Feng L, Brown SC, Sewry CA, Rutherford M, Shapira Y, Abbs S, Muntoni F.

Ann Neurol. 2006 Nov;60(5):603-610. doi: 10.1002/ana.21006.

PubMed [citation]
PMID:
17044012

Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.

Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, Straub V, Robb S, Quinlivan R, Feng L, Jimenez-Mallebrera C, Mercuri E, Manzur AY, Kinali M, Torelli S, Brown SC, Sewry CA, Bushby K, Topaloglu H, North K, Abbs S, Muntoni F.

Brain. 2007 Oct;130(Pt 10):2725-35. Epub 2007 Sep 18.

PubMed [citation]
PMID:
17878207
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV000813974.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change creates a premature translational stop signal (p.Phe135Alafs*2) in the FKTN gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with FKTN-related disease. Loss-of-function variants in FKTN are known to be pathogenic (PMID: 17044012, 17878207, 18752264). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 30, 2024